When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LXRX - Lexicon Pharmaceuticals: Blue Sky Aplenty Revenue Not So Much
Lexicon Pharmaceuticals Inc.
2024-05-28 06:47:51 ET
Summary
Lexicon Pharmaceuticals has a strong cash position and multiple late-stage assets.
However, the company is facing low revenues and high expenses.
Overall, Lexicon Pharmaceuticals' financial situation presents a mixed outlook for the company.
This is my first look at Lexicon Pharmaceuticals ( LXRX ). I am intrigued by its nice cash, its one approved and several late-stage assets. I am disheartened by its measly revenues and its hefty expenses. Its overall story highlights another tough day in pharma land for sure....